Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
US Army
McKesson
McKinsey
Colorcon
Argus Health
QuintilesIMS
Medtronic
Chinese Patent Office

Generated: April 25, 2018

DrugPatentWatch Database Preview

CUBICIN RF Drug Profile

« Back to Dashboard

When do Cubicin Rf patents expire, and when can generic versions of Cubicin Rf launch?

Cubicin Rf is a drug marketed by Cubist Pharms Llc and is included in one NDA. There is one patent protecting this drug.

This drug has thirty patent family members in nineteen countries.

The generic ingredient in CUBICIN RF is daptomycin. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the daptomycin profile page.
Summary for CUBICIN RF
Drug patent expirations by year for CUBICIN RF
Pharmacology for CUBICIN RF
Ingredient-typeLipopeptides
Drug ClassLipopeptide Antibacterial
Medical Subject Heading (MeSH) Categories for CUBICIN RF
Synonyms for CUBICIN RF
103060-53-3
Cidecin
CS-1857
Cubicin
Cubicin (TN)
D01080
D4229
Dapcin
Daptomicina
Daptomicina [Spanish]
DAPTOMYCIN
Daptomycin (JAN/USAN/INN)
Daptomycin for injection
Daptomycine
Daptomycine [French]
Daptomycinum
Daptomycinum [Latin]
Deptomycin
HY-B0108
LY 146032
LY-146032
LY146032
MK-3009
MolPort-046-033-485
NWQ5N31VKK
SCHEMBL13491700
UNII-NWQ5N31VKK

US Patents and Regulatory Information for CUBICIN RF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cubist Pharms Llc CUBICIN RF daptomycin POWDER;INTRAVENOUS 021572-003 Jul 6, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Cubist Pharms Llc CUBICIN RF daptomycin POWDER;INTRAVENOUS 021572-003 Jul 6, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Cubist Pharms Llc CUBICIN RF daptomycin POWDER;INTRAVENOUS 021572-003 Jul 6, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for CUBICIN RF

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,835,382 Lipopeptide compositions and related methods ➤ Try a Free Trial
9,662,397 Lipopeptide compositions and related methods ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for CUBICIN RF

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0022 France ➤ Try a Free Trial PRODUCT NAME: DAPTOMYCINE; REGISTRATION NO/DATE: EU/1/05/328/001-002 20060119
22/2006 Austria ➤ Try a Free Trial PRODUCT NAME: DAPTOMYCIN
2006 00018 Denmark ➤ Try a Free Trial PRODUCT NAME: DAPTOMYCIN
/2006 Austria ➤ Try a Free Trial PRODUCT NAME: DAPTOMYCIN; REGISTRATION NO/DATE: EU/1/05/328/001 UND 002 20060119
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Mallinckrodt
US Department of Justice
US Army
UBS
Johnson and Johnson
Covington
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.